Professor Sir John Burn

Professor Sir John Burn has been a Consultant Clinical Geneticist in the Northern Genetics Service since 1984, and a Professor of Clinical Genetics since 1991 at Newcastle University with over 500 publications. He was knighted for services to Medicine and Healthcare in 2010. He is the Chief Investigator of CaPP, the international Cancer Prevention Programme, which has shown aspirin can prevent hereditary colorectal cancer. Professor Burn conceived and helped create the Millennium Landmark Centre for Life which houses an education and science centre alongside the Institute of Genetic Medicine and Northgene Ltd, the identity testing company he launched in 1995. He was former Chair of the British Society for Genetic Medicine, and of European Society of Human Genetics. He is a non-executive director at NHS England, and Chair to DNA device company, QuantuMDx.